Balanitis xerotica obliterans in children and adolescents: A literature review and clinical series
Author
dc.contributor.author
Celis Lagos, María Soledad
Author
dc.contributor.author
Reed, Francisco
es_CL
Author
dc.contributor.author
Murphy, Feilim
es_CL
Author
dc.contributor.author
Adams, Stephen
es_CL
Author
dc.contributor.author
Gillick, John
es_CL
Author
dc.contributor.author
Abdelhafeez, Abdelhafeez H.
es_CL
Author
dc.contributor.author
López, Pedro José
es_CL
Admission date
dc.date.accessioned
2014-12-12T14:36:53Z
Available date
dc.date.available
2014-12-12T14:36:53Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Journal of Pediatric Urology (2014) 10, 34e39
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.jpurol.2013.09.027
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129363
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Objective: Balanitis xerotica obliterans (BXO) is a chronic inflammatory disease
that is considered as male genital variant lichen sclerosis. The incidence varies greatly in
different series; diagnosis is mostly clinical but histopathological confirmation is mandatory.
Various treatments are described, but there is no consensus that one is the best.
Materials and methods: A literature review was made of BXO and lichen sclerosis in boys under
18 years of age, between 1995 and 2013, analyzing demographic dates, treatments and outcomes.
In addition to that, we reviewed BXO cases treated in our centers in the last 10 years.
Results: After literature review, only 13 articles matched the inclusion criteria. Analyzing
those selected, the global incidence of BXO is nearly 35% among circumcised children.
Described symptoms are diverse and the low index of clinical suspicion is highlighted. The main
treatment is circumcision, with use of topical and intralesional steroids and immunosuppressive
agents.